What changed
$KR — BUY 📊 | 6 MONTHS THESIS
🧭 Conviction: HIGH
The Kroger Co. operates as a food and drug retailer in the United States.
🎯 FQ2 FY2027 (ends Jul) | reported Jun 18 | EPS $1.58 vs $1.46 🟢
💡 Consensus prices in persistent margin decay and market share loss from competitors like Amazon and Walmart, but Kroger’s recent 8.2% EPS beat and stable identical sales growth show the business is holding ground; the 8.9x trailing P/E is a relic of overstated fears, not deteriorating fundamentals.
📉 Reward/risk: 3.1:1
🏢 Business Quality: 7/10
📊 Valuation: cheap — trailing P/E 8.9x vs 5-year average 12.3x and peer median 12.1x; FCF yield estimated over 10%.
🔮 Catalyst: Next quarterly report (FQ3 FY2027, est. Sep 2026)
💰 Entry: $56.24, stop $52.0, target $69.5
⚖️ Buy Kroger for a 6–12 month mean-reversion play as the 8.9x P/E on stable earnings is unjustified and likely to expand to 11–12x following continued execution.
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/KR0702